These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 6146579)

  • 1. Prolactin response to sulpiride in ovulatory women (a clue for the screening of hyperprolactinemic states).
    Nahoum CR; Pantaleão JA; Freire RR; Franco S
    Int J Fertil; 1984; 29(1):20-4. PubMed ID: 6146579
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolactin responsiveness to repeated decremental doses of sulpiride.
    Tormey WP; Buckley MP; Taaffe W; O'Kelly DA; Darragh A
    Horm Metab Res; 1981 Aug; 13(8):454-5. PubMed ID: 7327523
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inter-relationships between the secretory dynamics of thyrotrophin-releasing hormone, thyrotrophin and prolactin in periovulatory mares: effect of hypothyroidism.
    Alexander SL; Irvine CH; Evans MJ
    J Neuroendocrinol; 2004 Nov; 16(11):906-15. PubMed ID: 15584931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum prolactin levels after a single and subchronic oral administration of chlorpromazine and sulpiride. A cross-over study in healthy volunteers.
    Männistö PT; Korttila K; Seppälä T
    Arzneimittelforschung; 1978; 28(1):76-8. PubMed ID: 580204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Aldosterone and prolactin secretion. I. Effects of sulpiride on plasma aldosterone levels in normal subjects].
    Frisina N; Costa G; Buemi M; Lasco A
    Boll Soc Ital Biol Sper; 1978 Dec; 54(23):2473-6. PubMed ID: 756746
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effects of somatostatin and sulpiride administration on prolactin secretion in normal adult subjects].
    Barreca T; Gallamini A; Gianrossi R; Masturzo P; Murialdo G; Nizzo MC; Polleri A; Rolandi E
    Boll Soc Ital Biol Sper; 1976 Dec; 52(24):2088-91. PubMed ID: 1030955
    [No Abstract]   [Full Text] [Related]  

  • 7. Pituitary and ovarian response to luteinizing hormone releasing factor in normal and sulpiride-induced hyperprolactinemic women.
    Yagi S; Nakano R
    Obstet Gynecol; 1982 Nov; 60(5):571-6. PubMed ID: 6815597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sulpiride and thyrotrophin releasing hormone loading test in patients with acromegaly.
    Zséli J; Földes J; Holló I; Kollin E; Horváth C; Gács G; Borvendég J
    Acta Med Acad Sci Hung; 1980; 37(4):357-64. PubMed ID: 6785978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Excessive prolactinemic response to sulpiride in patients with mild essential hypertension. Index of diminished hypothalamic dopaminergic activity].
    Paladini G; Sponza E; Geatti O; Di Chiara F; Bertolutti T
    Minerva Med; 1980 Sep; 71(31):2229-35. PubMed ID: 6999383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Blood prolactin in 845 cases of clinically idiopathic sexual dysfunction].
    Buvat J; Buvat-Herbaut M; Lemaire A; Racadot A; Fossati P
    Nouv Presse Med; 1982 Nov; 11(48):3543-6. PubMed ID: 6818525
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bromocriptine for induction of ovulation in hyperprolactinemic amenorrhea.
    Nillius SJ
    Acta Eur Fertil; 1984; 15(2):83-91. PubMed ID: 6475464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction between salsolinol (SAL) and thyrotropin-releasing hormone (TRH) or dopamine (DA) on the secretion of prolactin in ruminants.
    Hashizume T; Shida R; Suzuki S; Kasuya E; Kuwayama H; Suzuki H; Oláh M; Nagy GM
    Domest Anim Endocrinol; 2008 Apr; 34(3):327-32. PubMed ID: 17976947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of dopamine on prolactin: interactions with cocaine self-administration by female rhesus monkeys.
    Mello NK; Mendelson JH; Drieze JM; Teoh SK; Kelly ML; Sholar JW
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1110-20. PubMed ID: 7932159
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prevention with sulpiride of the inhibitory effect of L-DOPA on prolactin secretion].
    Rolandi E; Barreca T; Masturzo P; Polleri A
    Boll Soc Ital Biol Sper; 1975 Jun; 51(12):751-4. PubMed ID: 1222097
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of sulpiride on serum prolactin levels in humans.
    Mancini AM; Guitelman A; Vargas CA; Debeljuk L; Aparicio NJ
    J Clin Endocrinol Metab; 1976 Jan; 42(1):181-4. PubMed ID: 1249187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of fenfluramine oral administration on serum prolactin levels in healthy and hyperprolactinemic women.
    Scarduelli C; Mattei AM; Brambilla G; Zavaglia C; Adelasco P; Cavioni V; Ferrari C
    Gynecol Obstet Invest; 1985; 19(2):92-6. PubMed ID: 3988149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolactin response following intravenous and oral sulpiride in healthy human subjects in relation to sulpiride concentrations.
    Wiesel FA; Alfredsson G; Ehrnebo M; Sedvall G
    Psychopharmacology (Berl); 1982; 76(1):44-7. PubMed ID: 6805007
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of ergovaline, loline, and dopamine antagonists on rat pituitary cell prolactin release in vitro.
    Strickland JR; Cross DL; Birrenkott GP; Grimes LW
    Am J Vet Res; 1994 May; 55(5):716-21. PubMed ID: 8067623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stimulation of human prolactin secretion by sulpiride.
    Kato Y; Ohgo S; Chihara K; Imura H
    Endocrinol Jpn; 1975 Oct; 22(5):457-60. PubMed ID: 813995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of prolactin-releasing response to salsolinol (SAL) and thyrotropin-releasing hormone (TRH) in ruminants.
    Hashizume T; Onodera Y; Shida R; Isobe E; Suzuki S; Sawai K; Kasuya E; Nagy GM
    Domest Anim Endocrinol; 2009 Feb; 36(2):99-104. PubMed ID: 19070987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.